Reprocessed Dialyzers Where Applicable

What Reprocessing Is and When It Applies

Dialyzer reprocessing (reuse) is the process of cleaning, testing, disinfecting, labeling, and storing a used dialyzer so it can be reused by the same patient at a later treatment. It is permitted only where the facility operates an approved reuse program that complies with AAMI reprocessing standards and CMS ESRD Conditions for Coverage (42 CFR 494). Many U.S. units now use single-use dialyzers only, so a technician must never assume reuse rules apply in every setting.

The single most important safety principle: a reprocessed dialyzer is patient-specific. Each dialyzer carries a label with the patient's name, a second identifier, and the reuse count. Using one patient's dialyzer on another patient is a catastrophic, never-event error that can transmit bloodborne pathogens. Verifying the patient label against the patient's identity is non-negotiable.

Performance and Germicide Verification

Reprocessing must confirm the dialyzer still performs and is safe. The central performance test is total cell volume (TCV) - the volume of blood the fiber bundle holds. Clotting and fiber loss shrink the TCV and reduce clearance.

• TCV must remain at least 80% of the original (baseline) volume. Below 80%, the dialyzer is discarded because it can no longer deliver the prescribed clearance.
• A pressure/leak (integrity) test confirms no fiber or housing leaks that could cause blood loss or a membrane breach.

Disinfection uses a germicide such as peracetic acid (most common), formaldehyde, or glutaraldehyde, which must dwell for the required contact time and then be completely removed before reuse.

The germicide-removal rule is a frequent exam item: two independent presence/absence tests must confirm the germicide is gone before connecting the patient, in addition to a thorough rinse and an air-free prime. Residual peracetic acid or formaldehyde reaching the blood causes hemolysis, chemical reactions, and severe symptoms.

The Pre-Use Checklist and Reuse Risks

Before a reprocessed dialyzer is connected, the technician confirms every item:

Benefits of reuse include supply and cost management and reduced first-use reactions, but the exam weights risk far more heavily. The serious hazards are patient mix-up, inadequate germicide removal, contamination/infection, a damaged or leaking membrane, and reduced clearance from a low TCV.

During treatment, watch for a reuse/first-use type reaction: unexplained fever, chills, chest or back pain, shortness of breath, hypotension, or signs of hemolysis (cherry-red or dark blood in the venous line, falling hematocrit). Any such finding requires immediate escalation per protocol - stop the suspected cause within scope, call the nurse, and document objective findings plus the dialyzer's identification.

Worked example: A technician picks up a reprocessed dialyzer and the label reads a different patient's name, even though the chair assignment is correct. The technician does not use it - a name mismatch is an absolute stop. The dialyzer is set aside, the nurse and reprocessing staff are notified, and the event is documented. Treating reuse dialyzers as interchangeable would risk a cross-patient exposure.

The Reprocessing Cycle, Step by Step

Understanding the order of reprocessing helps you see why each pre-use check exists. A typical cycle proceeds:

1. Rinse and clean - flush blood and debris from the blood and dialysate compartments immediately after treatment so proteins do not fix to the membrane.
2. Performance test (TCV) - measure total cell volume against the original baseline; discard if below 80%.
3. Integrity / leak test - pressure-test the fibers and housing for leaks.
4. Disinfect with germicide - fill with peracetic acid, formaldehyde, or glutaraldehyde for the required contact time.
5. Label and store - record patient name, reuse number, date, and operator; store in a controlled, dated location.
6. Pre-use checks - at the next treatment, verify label, germicide removal (two tests), appearance, and integrity before connecting.

Each step maps to a hazard: skip the rinse and you get inadequate cleaning and reactions; skip the TCV and you under-dialyze; skip the leak test and you risk blood loss or a membrane breach; skip the germicide-removal test and you expose blood to a caustic chemical.

Single-Use vs Reuse and the Scope Boundary

Because many facilities have moved to single-use dialyzers, the exam expects you to recognize that reuse rules apply only where an approved program exists - you never improvise reprocessing in a single-use unit, and you never apply single-use assumptions to a reuse dialyzer.

The trade-off is straightforward. Reuse offers cost and supply benefits and may reduce first-use reactions, but it introduces the dangers of patient mix-up, residual germicide, contamination, leaks, and declining clearance. The CCHT blueprint weights the risks heavily, so the safest answer almost always respects labeling, patient assignment, testing, storage, and facility policy over convenience.

The technician's scope is to verify and escalate, not to judge a borderline dialyzer fit for use against policy. A failed TCV, a positive germicide test, a leak, an abnormal appearance, a wrong label, or any patient reaction is a stop-and-escalate event - the dialyzer leaves service and qualified staff and the nurse are notified, with objective documentation of what was observed and the dialyzer's identifying information.